FDA Inspection 879074 — Lexington Cln IRB #1
The FDA completed an inspection of Lexington Cln IRB #1 on February 20, 2014 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 20, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, KY (United States)
Additional Details
IRB